glp-1 drugs and gastroparesis Gastroparesis: What Patients Should Know? Clinical Recommendations to Manage Gastrointestinal

Williams G

Open questions in the GHK-Cu field include the specific cellular targets responsible for the broad transcriptomic effects, the relationship between the copper-delivery role and the direct peptide-only effects (if any), the comparative biology of GHK-Cu and related copper-peptides in defined cellular contexts, and the translation of cell-culture and animal-model findings to clinical-research endpoints under controlled study conditions

Should a patient stop their long-acting (insulin glargine or detemir) when starting a Glucagon-like peptide-1 (GLP-1) receptor agonist, such as liraglutide?

Dissolution behavior and thermodynamic properties of apixaban in pure and mixed solvents